Ketamine for treatment-resistant depression
Treatments studied
Part of Mental health clinical trials.
This study tests if intravenous ketamine can help people with treatment-resistant depression who haven't found relief from at least two other treatments. If you qualify, you'll receive ketamine infusions to see if it improves your mood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have major depression (without psychosis) that hasn't gotten better after trying at least two other treatments.
- You are able to understand and agree to the study procedures.
- You are not currently taking certain medications that could interfere with ketamine.
- You do not have bipolar disorder, schizophrenia, active PTSD, or a substance use disorder.
- Your health is stable enough to safely receive ketamine infusions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether ketamine, given with talk therapy, can help people whose depression hasn't improved with at least two antidepressants. It aims to see if this combination can reduce depression symptoms.
This study tests how a single dose of ketamine affects certain brain and body markers in people with severe depression. It aims to find better ways to predict who will respond to ketamine, which may help personalize depression treatment in the future.
This study tests whether a single dose of ketamine can change brain wave patterns (called gamma oscillations) in people with treatment-resistant depression. Researchers want to see if these brain waves can predict who will feel better after treatment.
This study combines behavioral activation therapy (a type of counseling that helps you re-engage in positive activities) with ketamine infusions to treat depression that hasn't improved with standard antidepressants. The goal is to see if adding this therapy makes ketamine work better and last longer.
This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.
This study tests whether ketamine, given as a liquid under the tongue or swallowed, can help people with depression that hasn't improved with at least two other antidepressants. It aims to see if this treatment is safe and effective.
Hear when a new Depressive Disorder, Treatment-Resistant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.